Tβ4 Shows Potential as a Combination Treatment for Diabetes-Induced Complications of the Cornea
/PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair,...
Source: prnewswire.com